Company intelligence / Profile preview

ThirdWave Partners

Madison, Wisconsin, United Statesramseyfg.com ↗

Ownership: Private
Development stage: Other

Overview

Third Wave Technologies developed and commercialized molecular diagnostic tests for DNA/RNA analysis, including FDA-cleared assays for HPV and cystic fibrosis. The company was acquired by Hologic in 2008 and ceased operations in 2012. Clinical results supported regulatory approval of several products; no ongoing programs post-acquisition.

Therapeutic areas: Rare DiseasesInfectious Diseases
Modalities: Molecular diagnostics (platform for DNA and RNA analysis)Small molecule (as part of diagnostic reagents)Nucleic acid-based technology
Industry: Molecular Diagnostics

Partnerships

Not specified in search results; likely included academic collaborations with University of Wisconsin-Madison.

Beyond the preview

Go deeper on ThirdWave Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ThirdWave Partners.

Explore the full profile